BDRX Stock Summary and Trading Ideas (Biodexa Pharmaceuticals PLC - American Depositary Shares | NASDAQ:BDRX)

Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.

Biodexa Pharmaceuticals PLC - American Depositary Shares trades on the NASDAQ stock market under the symbol BDRX.

As of April 10, 2026, BDRX stock price climbed to $3.36 with 49,123 million shares trading.

BDRX has a beta of 0.74, meaning it tends to be less sensitive to market movements. BDRX has a correlation of 0.01 to the broad based SPY ETF.

BDRX has a market cap of $10.89 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, BDRX traded as high as $31,750.00 and as low as $2.95.

BDRX has underperformed the market in the last year with a price return of -95.7% while the SPY ETF gained +30.9%. BDRX has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -71.4% and +2.7%, respectively, while the SPY returned -1.8% and +7.2%, respectively.

BDRX support price is $2.88 and resistance is $3.62 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BDRX shares will trade within this expected range on the day.